News and Events

Michael Lichten, Ph.D.; Deborah K. Morrison, Ph.D.; Mary N. Carrington, Ph.D.; Susan M. Lea, D.Phil., F.Med.Sci.

Four CCR researchers receive high honors

CCR Senior Investigators Michael Lichten, Ph.D., Deborah Morrison, Ph.D., Mary Carrington, Ph.D, and Susan Lea, D.Phil., F.Med.Sci., have been elected to notable scientific academies and societies in recognition of their significant and impactful research accomplishments.

Elaine S. Jaffe receives HHS Career Achievement Award

Elaine S. Jaffe, M.D., NIH Distinguished Investigator in the Laboratory of Pathology, was awarded a 2022 Career Achievement Award by the Department of Health and Human Services in recognition of her groundbreaking advances in the diagnosis and treatment of patients with blood cancers.

Male patient discusses pain with female doctor

Clinical trial researching PSMA imaging in prostate cancer

A clinical trial led by Deborah E. Citrin, M.D., Senior Investigator in the Radiation Oncology Branch, is researching prostate-specific membrane antigen (PSMA) imaging to evaluate response to radiation treatment in patients with prostate cancer.

a group of killer T cells (light blue) surround a cancer cell (dark red/black)

Computational model finds signatures of T cell resilience in solid tumors

Evaluating T cell resilience can help researchers predict — and possibly improve — immunotherapy outcomes.

Clinical trial researching therapy for some small cell lung cancers

Anish Thomas, M.B.B.S., M.D., Lasker Clinical Research Scholar in the Developmental Therapeutics Branch, is leading NCI’s participation in a trial researching therapies for small cell lung cancer.

Kandice Tanner receives Arthur S. Flemming Award

Kandice Tanner, Ph.D., a Senior Investigator in the Laboratory of Cell Biology, is a recipient of the 2021 Arthur S. Flemming Awards, which honor the accomplishments of midcareer federal employees. Dr. Tanner received the award for her breakthrough discovery that patterns of cancer spread in humans can be recreated in zebrafish. This novel animal model allows researchers to address organ-specific drug responses and develop effective immunotherapies in a preclinical platform.

Clinical trial researches therapy for VEXAS syndrome

A clinical trial led by Dennis Hickstein, M.D., Senior Investigator in the Immune Deficiency Cellular Therapy Program, is researching a therapy for people with VEXAS (Vacuoles, E1 Enzyme, X-linked, Autoinflammatory, Somatic) syndrome.

Protein signature in the blood linked to prostate cancer lethality in men of African ancestry

African American men have an increased risk for lethal prostate cancer. CCR researchers have found that an immunity-related protein signature in the blood is more prevalent in men of African ancestry, which may help explain this devastating health disparity.

Clinical trial researches three-part immunotherapy regimen for gastric or head and neck cancer

Jason M. Redman, M.D., Assistant Research Physician in the Genitourinary Malignancies Branch, is leading a study researching a three-part immunotherapy regimen in adults with gastric or head and neck cancer.

CCR scientists to present at 2022 AACR Annual Meeting in New Orleans

The American Association for Cancer Research (AACR) Annual Meeting is the focal point of the cancer research community, where scientists, clinicians, other health care professionals, survivors, patients, and advocates gather to share the latest advances in cancer science and medicine. Several CCR scientists will present their research at the AACR Annual Meeting.

Breadcrumb